Tags

Type your tag names separated by a space and hit enter

[COVID-19 and thromboprophylaxis: Recommendations for our clinical practice in Primary Care].
Semergen. 2020 Oct; 46(7):479-486.S

Abstract

The new coronavirus (SARS-CoV-2) is responsible for a severe acute respiratory syndrome. Among its manifestations, it can develop a thrombotic disease, both venous and arterial, due to excessive inflammation that affects the vascular system, with platelet activation and endothelial dysfunction, among other mechanisms. Thrombosis is associated with SARS-CoV-2 infection, increasing its severity and conferring a worse prognosis. Our performance as Family Physicians can contribute important actions in the management and control of this severe complication. Considering that many of our patients already receive antithrombotic or anticoagulant therapy, the fact that they may develop a COVID-19 infection will have implications for the choice, dosage and control of their treatment. In this document we review, with the information currently available, the relationship between disease caused by SARS-CoV-2 and thrombosis, as well as its management with a focus on Primary Care.

Links

PMC Free PDF

Authors+Show Affiliations

Piera Carbonell A
Centro de Salud Luanco, Gozón, Asturias, España. Electronic address: apiecar@hotmail.com.
Frías Vargas M
Centro de Salud Comillas, Madrid, España.
García Vallejo O
Centro de Salud Comillas, Madrid, España.
García Lerín A
Centro de Salud Almendrales, Madrid, España.
Cabrera Ferriols MA
Centro de Salud San Vicente del Raspeig, San Vicente del Raspeig, Alicante, España.
Peiró Morant J
Centro de Salud Ponent, Andratx, Mallorca, Illes Balears, España.
Carrasco Carrasco E
Centro de Salud de Abarán, Abarán, Murcia, España.
en nombre del Grupo de trabajo de Vasculopatías de SEMERGEN
No affiliation info available

MeSH

AnticoagulantsBetacoronavirusCOVID-19Coronavirus InfectionsFamily PracticeHumansPandemicsPneumonia, ViralPrimary Health CareRisk AssessmentSARS-CoV-2ThrombosisVenous Thromboembolism

Pub Type(s)

Consensus Development Conference
Journal Article
Practice Guideline

Language

spa

PubMed ID

33046353

Citation

Piera Carbonell, A, et al. "[COVID-19 and Thromboprophylaxis: Recommendations for Our Clinical Practice in Primary Care]." Semergen, vol. 46, no. 7, 2020, pp. 479-486.
Piera Carbonell A, Frías Vargas M, García Vallejo O, et al. [COVID-19 and thromboprophylaxis: Recommendations for our clinical practice in Primary Care]. Semergen. 2020;46(7):479-486.
Piera Carbonell, A., Frías Vargas, M., García Vallejo, O., García Lerín, A., Cabrera Ferriols, M. A., Peiró Morant, J., & Carrasco Carrasco, E. (2020). [COVID-19 and thromboprophylaxis: Recommendations for our clinical practice in Primary Care]. Semergen, 46(7), 479-486. https://doi.org/10.1016/j.semerg.2020.07.007
Piera Carbonell A, et al. [COVID-19 and Thromboprophylaxis: Recommendations for Our Clinical Practice in Primary Care]. Semergen. 2020;46(7):479-486. PubMed PMID: 33046353.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [COVID-19 and thromboprophylaxis: Recommendations for our clinical practice in Primary Care]. AU - Piera Carbonell,A, AU - Frías Vargas,M, AU - García Vallejo,O, AU - García Lerín,A, AU - Cabrera Ferriols,M A, AU - Peiró Morant,J, AU - Carrasco Carrasco,E, AU - ,, Y1 - 2020/09/18/ PY - 2020/05/15/received PY - 2020/07/16/revised PY - 2020/07/30/accepted PY - 2020/10/14/pubmed PY - 2020/12/1/medline PY - 2020/10/13/entrez KW - Atención Primaria KW - COVID-19 KW - Pandemia KW - Pandemic KW - Primary care KW - SARS-CoV-2 KW - Thromboprophylaxis KW - Thrombosis KW - Tromboprofilaxis KW - Trombosis SP - 479 EP - 486 JF - Semergen JO - Semergen VL - 46 IS - 7 N2 - The new coronavirus (SARS-CoV-2) is responsible for a severe acute respiratory syndrome. Among its manifestations, it can develop a thrombotic disease, both venous and arterial, due to excessive inflammation that affects the vascular system, with platelet activation and endothelial dysfunction, among other mechanisms. Thrombosis is associated with SARS-CoV-2 infection, increasing its severity and conferring a worse prognosis. Our performance as Family Physicians can contribute important actions in the management and control of this severe complication. Considering that many of our patients already receive antithrombotic or anticoagulant therapy, the fact that they may develop a COVID-19 infection will have implications for the choice, dosage and control of their treatment. In this document we review, with the information currently available, the relationship between disease caused by SARS-CoV-2 and thrombosis, as well as its management with a focus on Primary Care. SN - 1578-8865 UR - https://www.unboundmedicine.com/medline/citation/33046353/[COVID_19_and_thromboprophylaxis:_Recommendations_for_our_clinical_practice_in_Primary_Care]_ DB - PRIME DP - Unbound Medicine ER -